Anavex Life Sciences Reports Fiscal 2023 First Quarter Financial Results
Anavex Life Sciences Announces Its Very First Scientific Educational Video News Release
Anavex Life Sciences Reports Positive Results from Phase 1 Clinical Trial of ANAVEX®3-71
Anavex Life Sciences Announces First Participant Enrolled in Phase 1 Study of ANAVEX®3-71 (AF710B)
Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)
Follow us on social media